Professor Paulo Stanga - TU Associate
Prof. Paulo E. Stanga. Consultant Ophthalmologist and Vitreoretinal Surgeon for the Manchester Royal Eye Hospital, Professor of Ophthalmology and Retinal Regeneration for the University of Manchester.
Prof. Stanga specialises in vitreo-retinal disorders that require either medical or surgical treatment, such as age-related macular degeneration (AMD), diabetic retinopathy and maculopathy, retinal vein occlusions, macular hole, retinal detachment and ocular trauma.
Since 1993, Prof. Stanga has worked in the development and application of new outpatient and surgical therapies and technologies such as retrobulbar Interferon alpha-2a, genetics of AMD, retinal pigment epithelium translocation surgery, macular translocation surgery, micropulse diode and Pascal® laser photocoagulation, Time and Spectral Domain and Swept-Source (DRI-OCT®) optical coherence tomography (OCT), wide-angle (Optos®) fundus fluorescein angiography and fundus autofluorescence technology, antiangiogenic intravitreal drugs and high speed phaco/vitrectomy surgical systems.
As Director of the Manchester Vision Regeneration (MVR) Lab, Prof. Stanga runs a Retinal Clinical-Research Fellowship Program and whilst a Member of the Scientific Committee of the Royal College of Ophthalmologists, in November 2012 will start his tenure as President of the Ophthalmic Imaging Association.
Prof. Stanga’s current research interests are in the pharmacological, surgical and laser treatment of proliferative diabetic retinopathy and macular oedema, laser-tissue interaction, phototoxicity and wound construction during vitrectomy surgery and electronic retinal implants for artificial vision or "bionic eye".